Emerging strategies in BRCA-positive pancreatic cancer

PURPOSE: We propose a treatment algorithm for PDAC with particular emphasis on BRCA1 or 2 mutation-positive patients. Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest diseases in the United States and Europe. BRCA1 and BRCA2 are among the most common of the known genetic mutations inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalewski, Adam, Szylberg, Łukasz, Saganek, Michał, Napiontek, Wojciech, Antosik, Paulina, Grzanka, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061050/
https://www.ncbi.nlm.nih.gov/pubmed/29777302
http://dx.doi.org/10.1007/s00432-018-2666-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061050/
https://www.ncbi.nlm.nih.gov/pubmed/29777302
http://dx.doi.org/10.1007/s00432-018-2666-9

Ejemplares similares